April 10, 2003
After six months of heated negotiations, Quintiles Transnational Corp. announced that the health-care company’s founder and chairman Dennis Gillings will acquire it for $1.7 billion.
On April 10, after six months of heated negotiations, Quintiles Transnational Corp. announced that the health-care company’s founder and chairman Dennis Gillings will acquire it for $1.7 billion. Mr. Gillings upped his original offer by $400 million to take the company private, offering shareholders a 18.9% premium on the April 9 closing price of their shares. Over the past six months, Willkie received international press for its role as counsel to Quintiles’ Special Committee in publications including The Wall Street Journal, The Daily Deal, Reuters and Bloomberg News. Michael Schwartz and Mark DiPaolo represented the Special Committee on the deal.